Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
about
Degradation of MEPE, DMP1, and release of SIBLING ASARM-peptides (minhibins): ASARM-peptide(s) are directly responsible for defective mineralization in HYPPhosphatonin washout in Hyp mice proximal tubules: evidence for posttranscriptional regulation.Healing of bone disease in X-linked hypophosphatemic rickets/osteomalacia. Induction and maintenance with phosphorus and calcitriol.Early treatment of familial hypophosphataemic rickets.Regulation of phosphate transport by fibroblast growth factor 23 (FGF23): implications for disorders of phosphate metabolism.X-linked hypophosphatemia (familial or sex-linked vitamin-D-resistant rickets). X-linked hypophosphatemic (Hyp) mice.Correction of proximal tubule phosphate transport defect in Hyp mice in vivo and in vitro with indomethacin.Correction of the mineralization defect in hyp mice treated with protease inhibitors CA074 and pepstatinHereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications.Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.Role of abnormal neutral endopeptidase-like activities in Hyp mouse bone cells in renal phosphate transport.1,25-Dihydroxyvitamin D as Monotherapy for XLH: Back to the Future?Familial hypophosphataemic rickets: experience with 24 children from Kuwait.
P2860
Q24648401-D5363F7D-0014-4EEE-B5B3-8E71329C884DQ34030128-DD279774-4393-4C78-BDBC-50DC80D4BBC1Q34629902-E7652432-6216-4590-A851-ED3C89A55898Q35118053-71DC9CA9-8C64-425B-92C6-9AE1C2F90CA3Q35151453-8CDF5A17-C6B2-4E11-9D7A-9D98920E8907Q35835000-99718767-B63C-49CE-B97C-FEDF214BA6BDQ35978987-493D99DE-9187-4775-9822-EE9C9206CA79Q35983157-CF453C63-5B2C-4230-B040-EA91C2D093D5Q36360389-AB45A0F4-E363-42DD-8DEA-74EC0CCFBE11Q36468902-2D140FF9-ABB6-4FBE-A244-F64D74394623Q38362148-B887DB5C-7108-4D86-9E4C-AEB485883DBEQ38879138-238B5194-4AEF-4B65-B7CC-77BD04103AD5Q50545495-59E16980-C164-482C-843C-0D4ACB35D235
P2860
Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia.
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Evaluation of a role for 1,25- ...... emic rickets and osteomalacia.
@en
Evaluation of a role for 1,25- ...... emic rickets and osteomalacia.
@nl
type
label
Evaluation of a role for 1,25- ...... emic rickets and osteomalacia.
@en
Evaluation of a role for 1,25- ...... emic rickets and osteomalacia.
@nl
prefLabel
Evaluation of a role for 1,25- ...... emic rickets and osteomalacia.
@en
Evaluation of a role for 1,25- ...... emic rickets and osteomalacia.
@nl
P2093
P2860
P356
P1476
Evaluation of a role for 1,25- ...... emic rickets and osteomalacia.
@en
P2093
J M Harrelson
M K Drezner
M R Haussler
P2860
P304
P356
10.1172/JCI109930
P407
P577
1980-11-01T00:00:00Z